
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+9
NKGen Biotech is a clinical-stage biotechnology company harnessing the power of the bodys immune system through the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. The mission of NKGen Biotech is to improve patients lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics. More information can be found on our website www.nkgenbiotech.com
Immunotherapy,autologous cell therapy,biotechnology,cellular therapeutics,nk cell therapy,biopharmaceutical,immuno-oncology,biotechnology,allogeneic cell therapy,oncology,cell therapy,alzheimer's disease,neurodegenerative disease,and parkinson's disease
Nkgen biotech, inc operates in the Biotechnology industry.
Nkgen biotech, inc's revenue is 11m - 100m
Nkgen biotech, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.